Results 11 to 20 of about 27,835 (183)

Thrombocytopenia and its Comparison with Plasmodium Vivax and Plasmodium Falciparum in Malaria Patients

open access: yesPakistan Journal of Medical Research, 2023
Background: Malaria in Pakistan is a serious public health problem and thrombocytopenia can serve as diagnostic predictive marker. Objective: The objective of present study was to find out the frequency of plasmodium vivax and falciparum in malaria ...
Maliha Ajmal   +5 more
doaj   +2 more sources

Comparative transcriptomic analysis of the malaria parasites Plasmodium falciparum and Plasmodium vivax sensitive and resistant strains

open access: yesРазработка и регистрация лекарственных средств, 2022
Introduction. Malaria is the sixth leading cause of death worldwide. According to a WHO survey (2019-2020), the total number of malaria deaths is estimated to be 409000. Plasmodium falciparum and Plasmodium vivax are major malaria parasites, particularly
S. Sakpal   +3 more
doaj   +1 more source

Insights into the elimination of vivax malaria in China

open access: yesInfectious Diseases of Poverty, 2023
Background Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics.
Fang Huang, Li Zhang, Zhi-Gui Xia
doaj   +1 more source

Global Epidemiology of Plasmodium vivax [PDF]

open access: yesThe American Journal of Tropical Medicine and Hygiene, 2016
Plasmodium vivax is the most widespread human malaria, putting 2.5 billion people at risk of infection. Its unique biological and epidemiological characteristics pose challenges to control strategies that have been principally targeted against Plasmodium falciparum Unlike P. falciparum, P.
Howes, R   +6 more
openaire   +3 more sources

Attacking Plasmodium vivax [PDF]

open access: yesThe American Journal of Tropical Medicine and Hygiene, 2016
Discussions beginning in 2012 ultimately led to a landmark document from the World Health Organization (WHO) titled, Control and Elimination of Plasmodium vivax: A Technical Brief, published in July 2015. That body of work represents multiple expert consultations coordinated by the WHO Global Malaria Program, along with technical consensus gathering ...
openaire   +3 more sources

Myocarditis associated with malarial fever: An unusual presentation

open access: yesAsian Journal of Medical Sciences, 2022
Malaria is endemic in India and complicated malaria is usually caused by Plasmodium (P) falciparum, but Plasmodium vivax can also cause life-threatening conditions in some cases.
Anoop Kumar   +5 more
doaj   +1 more source

Plasmodium vivaxMalaria

open access: yesEmerging Infectious Diseases, 2005
We report 11 cases of severe Plasmodium vivax malaria in Bikaner (western India). Patients exhibited cerebral malaria, renal failure, circulatory collapse, severe anemia, hemoglobinurea, abnormal bleeding, acute respiratory distress syndrome, and jaundice.
Dhanpat K. Kochar   +5 more
openaire   +3 more sources

COVID-19 Associated Imported Plasmodium vivax Malaria Relapse: First Reported Case and Literature Review

open access: yesResearch and Reports in Tropical Medicine, 2021
Zubair Shahid,1 Nadia Karim,1 Fakhar Shahid,2 Zohaib Yousaf1,3 1Internal Medicine, Hamad Medical Corporation, Doha, Qatar; 2General Surgery, Hamad Medical Corporation, Doha, Qatar; 3Dresden International University, Dresden, GermanyCorrespondence: Zubair
Shahid Z, Karim N, Shahid F, Yousaf Z
doaj  

Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon

open access: yesBrazilian Journal of Infectious Diseases, 2010
This report describes the development of hemolysis in eighteen glucose-6-phosphate dehydrogenase deficient patients treated for Plasmodium vivax malaria with chloroquine and primaquine.
Wilson M. Ramos Júnior   +5 more
doaj   +1 more source

The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos

open access: yesMalaria Journal, 2019
Background Adding 8-aminoquinoline to the treatment of falciparum, in addition to vivax malaria, in locations where infections with both species are prevalent could prevent vivax reactivation.
Lorenz von Seidlein   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy